| (Values in U.S. Thousands) | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 | Dec, 2019 |
| Sales | 0 | 0 | 0 | 0 | 0 |
| Sales Growth | unch | unch | unch | unch | unch |
| Net Income | -10,380 | -3,550 | -3,730 | -5,150 | -25,910 |
| Net Income Growth | -192.39% | +4.83% | +27.57% | +80.12% | -20.23% |
Avenue Therapeutics Inc (ATXI)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.3620 +0.0070 (+1.97%) 03/21/25 [OTC US]
N/A x N/A N/A x N/A
Post-market 0.3620 unch (unch) 15:53 ET
for Fri, Mar 21st, 2025
Avenue Therapeutics, Inc. is a specialty pharmaceutical company. It acquires, licenses, develops and commercializes products principally for use in the acute/intensive care hospital setting. Avenue Therapeutics, Inc. is based in New York, United States.
Fiscal Year End Date: 12/31